Further, the current global environment is forcing the industry to rapidly embrace new ways of approaching clinical data collection from patients who may not be accessible in the traditional sense. With the introduction of virtual components in decentralized environments, clinical study teams and healthcare professionals now have the ability to collect in-depth, invaluable patient data to more efficiently evaluate the safety, efficacy, and benefit of a drug, device, or therapy.